Outcome Following Local‐Regional Recurrence in Women with Early‐Stage Breast Cancer: Impact of Biologic Subtype

E-ISSN： 1524-4741|21|2|161-167

ISSN： 1075-122x

Source： THE BREAST JOURNAL, Vol.21, Iss.2, 2015-03, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The evolving role of adjuvant radiotherapy for elderly women with early‐stage breast cancer

CANCER, Vol. 121, Iss. 14, 2015-07 ,pp. : 2331-2340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 554-558

Karger

Access to resources Recommend Favorite

Breast-Conserving Therapy for Early-Stage Breast Cancer in Chinese Women: A Meta-Analysis of Case-Control Studies

Oncology Research and Treatment, Vol. 35, Iss. 3, 2012-02 ,pp. : 133-139

Karger

Access to resources Recommend Favorite

Mastectomy and breast‐conserving therapy confer equivalent outcomes in young women with early‐stage breast cancer

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 5, 2015-09 ,pp. : 335-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer

By Lipsitz Michael Delea Thomas E. Guo Amy

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2315-2328

Informa Healthcare

Access to resources Recommend Favorite